Company Filing History:
Years Active: 2020
Title: The Innovations of James Copp
Introduction
James Copp is an accomplished inventor based in Silverthorne, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work focuses on advancing therapies for conditions associated with angiogenesis.
Latest Patents
James Copp holds a patent for HPTP-Beta inhibitors. This patent discloses compounds that are effective for the activation of Tie-2 and inhibition of HPTP-beta. These compounds have the potential to provide effective therapy for various conditions related to angiogenesis, including ocular conditions. Additionally, the patent includes formulations aimed at increasing solubility, which is crucial for the efficacy of these compounds.
Career Highlights
Copp is currently associated with Aerpio Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions. His work at Aerpio has positioned him as a key player in the pharmaceutical industry, particularly in the area of drug development targeting angiogenesis.
Collaborations
James Copp has collaborated with notable colleagues, including John M. Janusz and Kevin Gene Peters. These collaborations have further enhanced the research and development efforts at Aerpio Pharmaceuticals, contributing to the advancement of innovative therapies.
Conclusion
James Copp's contributions to the field of pharmaceuticals, particularly through his patent on HPTP-Beta inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in the treatment of angiogenesis-related conditions.